Archive for March, 2009

Pristiq: New Antidepressant or Merely a Patent Extender?

The newest entry into the antidepressant market is Pristiq (desvenlafaxine).Pristiq (desvenlafaxine), is in the SNRI category of antidepressants and is manufactured by the Wyeth Corporation. This drug received FDA approval in March, 2008. Faced with the fact that Wyeth is losing patent protection for its top-selling antidepressant Effexor XR(venlafaxine XR), the company needed a brand [...]

Direct-to-Consumer Advertising for Prescription Drugs

Welcome

Welcome clinicians, colleagues, friends and caregivers to our blogposts.  We hope these commentaries will bring fresh perspectives, valuable insights and solutions to your mental health medication issues. Our desire is that you find something of interest in each of these posts, and that you will look forward to receiving them on a weekly basis.  We [...]